Yaodong C, Zhang Y, Feng G, Lei Y, Liu Q, Liu Y
PLoS One. 2023; 18(9):e0286569.
PMID: 37768984
PMC: 10538739.
DOI: 10.1371/journal.pone.0286569.
Hadoush H, Alqudah A, Banihani S, Al-Jarrah M, Amro A, Aldajah S
Sleep Sci. 2021; 14(Spec 1):25-30.
PMID: 34917270
PMC: 8663735.
DOI: 10.5935/1984-0063.20200083.
Ashton A, Jagannath A
Front Neurosci. 2020; 14:636.
PMID: 32655359
PMC: 7324687.
DOI: 10.3389/fnins.2020.00636.
Cecon E, Oishi A, Jockers R
Br J Pharmacol. 2017; 175(16):3263-3280.
PMID: 28707298
PMC: 6057902.
DOI: 10.1111/bph.13950.
Jockers R, Delagrange P, Dubocovich M, Markus R, Renault N, Tosini G
Br J Pharmacol. 2016; 173(18):2702-25.
PMID: 27314810
PMC: 4995287.
DOI: 10.1111/bph.13536.
Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials.
Chen S, Shi L, Liang F, Xu L, Desislava D, Wu Q
Mol Neurobiol. 2015; 53(6):4046-4053.
PMID: 26189834
DOI: 10.1007/s12035-015-9350-8.
Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial.
de Jonghe A, van Munster B, Goslings J, Kloen P, van Rees C, Wolvius R
CMAJ. 2014; 186(14):E547-56.
PMID: 25183726
PMC: 4188685.
DOI: 10.1503/cmaj.140495.
Distribution, function and physiological role of melatonin in the lower gut.
Chen C, Fichna J, Bashashati M, Li Y, Storr M
World J Gastroenterol. 2011; 17(34):3888-98.
PMID: 22025877
PMC: 3198018.
DOI: 10.3748/wjg.v17.i34.3888.
Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting.
Zisapel N
Cell Mol Neurobiol. 2002; 21(6):605-16.
PMID: 12043836
PMC: 11533843.
DOI: 10.1023/a:1015187601628.
Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats.
Shacoori V, Saiag B, Lemay V, Girre A, Rault B
J Endocrinol Invest. 1996; 19(2):76-82.
PMID: 8778169
DOI: 10.1007/BF03349840.
Effects of melatonin on PRL secretion during different photoperiods of the day in prepubertal and pubertal healthy subjects.
Mauri R, Lissoni P, Resentini M, de Medici C, Morabito F, Djemal S
J Endocrinol Invest. 1985; 8(4):337-41.
PMID: 4067205
DOI: 10.1007/BF03348509.
The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.
Esposti D, Lissoni P, Mauri R, ROVELLI F, Orsenigo L, Pescia S
J Endocrinol Invest. 1988; 11(2):103-6.
PMID: 3361078
DOI: 10.1007/BF03350114.
A clinical study on the relationship between the pineal gland and the opioid system.
Lissoni P, Esposti D, Esposti G, Mauri R, Resentini M, Morabito F
J Neural Transm. 1986; 65(1):63-73.
PMID: 2937880
DOI: 10.1007/BF01249612.
Melatonin receptors revisited.
Zisapel N
J Neural Transm. 1988; 73(1):1-5.
PMID: 2841420
DOI: 10.1007/BF01244617.
Melatonin effects on prolactin secretion in pituitary-grafted female rats.
Esquifino A, Villanua M, Agrasal C, Reiter R, Tresguerres J
J Endocrinol Invest. 1989; 12(3):171-6.
PMID: 2656832
DOI: 10.1007/BF03349954.
A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemia.
Lissoni P, Mainini E, Mazzi C, Cattaneo G, Barni S
J Endocrinol Invest. 1990; 13(2):85-9.
PMID: 2329263
DOI: 10.1007/BF03349513.
D1-dopamine receptors activate c-fos expression in the fetal suprachiasmatic nuclei.
Weaver D, Rivkees S, Reppert S
Proc Natl Acad Sci U S A. 1992; 89(19):9201-4.
PMID: 1384044
PMC: 50093.
DOI: 10.1073/pnas.89.19.9201.
Modification by oxazepam of the diurnal variations in brain 125I-melatonin binding sites in sham-operated and pinealectomized rats.
Anis Y, Nir I, Schmidt U, Zisapel N
J Neural Transm Gen Sect. 1992; 89(3):155-66.
PMID: 1327001
DOI: 10.1007/BF01250668.
